ACP-204
ACP-204-008
Phase 3 small_molecule active
Quick answer
ACP-204 for Alzheimer's Disease Psychosis is a Phase 3 program (small_molecule) at ACADIA PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- ACADIA PHARMACEUTICALS INC
- Indication
- Alzheimer's Disease Psychosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active